Kamil Hoffmann

Kamil Hoffmann

Auto-generated profile, based on publicly available information

Kamil Hoffmann

Bioinorganic Chemistry Research Group, Faculty of Chemistry, Nicolaus Copernicus University in Toruń, Gagarina 7, 87-100 Toruń, Poland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 July 2017 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
KHKamil Hoffmann
Kamil Hoffmann
JWJoanna Wiśniewska
Joanna Wiśniewska
AWAndrzej Wojtczak
Andrzej Wojtczak
JSJERZY SITKOWSKI
JERZY SITKOWSKI
ADAgnieszka Denslow
Agnieszka Denslow
IŁIwona Łakomska
Iwona Łakomska


14 August 2015 in Journal of Coordination Chemistry
Verified
Journal Article
Closed access
KHKamil Hoffmann
Kamil Hoffmann
IŁIwona Łakomska
Iwona Łakomska
JWJoanna Wiśniewska
Joanna Wiśniewska
AKAnna Kaczmarek-Kędziera
Anna Kaczmarek-Kędziera
JWJoanna Wietrzyk
Joanna Wietrzyk
The reaction of silver acetate with cis-[PtI2(dbtp)2], where dbtp = 5,7-ditertbutyl-1,2,4-triazolo-[1,5-a]pyrimidine, yielded cis-[Pt(OOCCH3)2(dbtp)2]·dmf (1). The complex has been analyzed by multinuclear magnetic resonance (1H, 13C, 15N), IR, and Raman. The compound formed two rotamers in CDCl3 and its spatial structures have been optimized using computational calculation. It was found that head-to-tail rotamer (1a) is more stable than its head-to-head counterpart (1b). In vitro antiproliferative activity against four tumor cell lines (A549, T47D, FaDu, and A2780cis) revealed in all cases significant cytotoxicity (IC50 = 0.26–1.80 μM), possessing IC50 values at least fivefold lower than cisplatin, carboplatin, and oxaliplatin (except A2780cis). The remarkable in vitro activity against T47D and A2780cis suggested the ability to overcome cisplatin resistance in these types of tumor cells. In addition, in vitro toxicity was evaluated against BALB/3T3 and has shown that the lipophilic platinum(II) complex (1) inhibits cell proliferation weaker than cisplatin and oxaliplatin. Additionally, cis-[Pt(OOCCH3)2(dbtp)2]·dmf exhibited selective activity, in contrast to cisplatin or oxaliplatin.

1 January 2014 in Journal of Molecular Structure
Verified
Journal Article
Closed access
IŁIwona Łakomska
Iwona Łakomska
KHKamil Hoffmann
Kamil Hoffmann
Tadeusz Mikolaj MuziolTadeusz Mikolaj Muziol
Tadeusz Mikolaj Muziol
JSJERZY SITKOWSKI
JERZY SITKOWSKI

Verified
Conference Paper
Closed access
KHKamil Hoffmann
Kamil Hoffmann
EMEwa Maj
Ewa Maj
AWAndrzej Wojtczak
Andrzej Wojtczak
JWJoanna Wietrzyk
Joanna Wietrzyk
IŁIwona Łakomska
Iwona Łakomska